Zein Shaban Ibrahim1,3, Mohamed Mohamed Ahmed2,4,Samir Ahmed El-Shazly2,5 and Mohamed Elsayed Alkafafy2,6
1Department of Physiology, Faculty of Medicine, 2Department of Biotechnology, College of Science, Taif University, Saudi Arabia
3Department of Physiology, 4Department of Biochemistry, Faculty of Veterinary Medicine, Kaferelsheikh University, Egypt
6Department of Histology, 5Department of Biochemistry, College of Veterinary Medicine, University of Sadat City, Egypt
ABSTRACT
Cytochrome P450 (CYPs) constitutes the major enzyme family capable of catalysing the oxidative biotransformation of most drugs. These are affected by a large number of factors including environmental elements. Widely practiced drinking of camel milk as a nutrient, therapy for some disease or even adjuvant with some drugs make it mandatory to investigate the possible CYPs modulator effects of camel milk. Forty-eight male Wistar rats were divided into 6 groups of 8 rats each. Groups were allocated as control, Camel milk (CM) treated, Sudan III (S.III) treated, S.III +CM, Phenobarbital (PB) or PB+CM.
CYP3A2, CYP 2B1, CYP 1A1 and CYP 1A2 mRNA were measured by semi-quantitative RT-PCR. Results showed that camel milk supplementation reduced the mRNA ex
Key words: Camel milk, CYPs, PB, S.III